Plain-English translation of NCT03353584 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether virtual reality—a technology that puts you in a relaxing, computer-generated environment through a special headset—can help reduce pain during a vaso-occlusive crisis (a severe pain episode caused by sickle cell disease). Half of the participants will receive standard pain treatment alone, while the other half will receive standard treatment plus a 15-minute virtual reality session designed to distract from pain.
Vaso-occlusive crises cause severe, sudden pain in people with sickle cell disease and are usually treated with fluids and strong pain medications. Researchers want to know if this treatment can help reduce pain and improve how quickly patients feel better during these painful episodes.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either standard care or standard care plus a 15-minute virtual reality session. You will have your pain measured at the start of your visit and at two more time points afterward. At the end, you'll complete a brief 5-minute survey about your experience. The study team will also collect information from your medical records about your pain scores, the medicines you received, and how long it took for your pain to improve.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United States